At the time of writing, Regenxbio Inc [RGNX] stock is trading at $8.89, up 2.89%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The RGNX shares have gain 18.22% over the last week, with a monthly amount glided 44.32%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Regenxbio Inc [NASDAQ: RGNX] stock has seen the most recent analyst activity on February 11, 2025, when Goldman downgraded its rating to a Neutral and also revised its price target to $14 from $38. Goldman initiated its recommendation with a Buy and recommended $38 as its price target on June 07, 2024. H.C. Wainwright started tracking with a Buy rating for this stock on March 11, 2024, and assigned it a price target of $36. In a note dated March 08, 2024, RBC Capital Mkts upgraded an Outperform rating on this stock and boosted its target price from $20 to $35.
For the past year, the stock price of Regenxbio Inc fluctuated between $5.03 and $16.26. Currently, Wall Street analysts expect the stock to reach $27 within the next 12 months. Regenxbio Inc [NASDAQ: RGNX] shares were valued at $8.89 at the most recent close of the market. An investor can expect a potential return of 203.71% based on the average RGNX price forecast.
Analyzing the RGNX fundamentals
According to Regenxbio Inc [NASDAQ:RGNX], the company’s sales were 156.72M for trailing twelve months, which represents an 469.79% jump. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at -1.0%, Pretax Profit Margin comes in at -1.01%, and Net Profit Margin reading is -1.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.53 and Total Capital is -0.41. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.29.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.51 points at the first support level, and at 8.13 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.18, and for the 2nd resistance point, it is at 9.47.
Ratios To Look Out For
It is important to note that Regenxbio Inc [NASDAQ:RGNX] has a current ratio of 2.93. Further, the Quick Ratio stands at 2.93, while the Cash Ratio is 1.22. Considering the valuation of this stock, the price to sales ratio is 2.85, the price to book ratio is 1.62.
Transactions by insiders
Recent insider trading involved Mills Kenneth T., Director, that happened on May 12 ’25 when 20602.0 shares were sold. Director, KENNETH MILLS completed a deal on May 12 ’25 to buy 20602.0 shares. Meanwhile, Officer VITTAL VASISTA bought 20041.0 shares on Dec 30 ’24.
